Luca Bolliger
No más puestos en curso
Perfil
Mr. Luca Bolliger is a Director-Communications & Business Development at NovImmune SA.
Mr. Bolliger was previously employed as Founder by Biopolo Ticino, Fundamental Analyst by BT&T Asset Management Ltd., a Member by Basel Institute for Immunology, and a Portfolio Manager by Hoffmann-La Roche, Inc.
He received his undergraduate degree from the Swiss Federal Institute of Technology.
Antiguos cargos conocidos de Luca Bolliger.
| Empresas | Cargo | Fin |
|---|---|---|
| Biopolo Ticino | Fundador | - |
BT&T Asset Management AG
 BT&T Asset Management AG Investment ManagersFinance BT&T Asset Management Ltd. (BT&T-AM) is an independent investment management firm which was established by Walter Meier in 1995. Based in Zurich, Switzerland, the firm manages assets for BT&T TimeLife AG, a closed-end mutual fund. | Corporate Officer/Principal | - |
| Basel Institute for Immunology | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
| NOVIMMUNE SA | Public Communications Contact | - |
Formación de Luca Bolliger.
| Swiss Federal Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
BT&T Asset Management AG
BT&T Asset Management AG Investment ManagersFinance BT&T Asset Management Ltd. (BT&T-AM) is an independent investment management firm which was established by Walter Meier in 1995. Based in Zurich, Switzerland, the firm manages assets for BT&T TimeLife AG, a closed-end mutual fund. | Finance |
Novimmune SA
 Novimmune SA Medical/Nursing ServicesHealth Services Novimmune SA discovers and develops antibody-based drugs targeted for the treatment of inflammatory diseases, immune-related disorders and cancer. The company was founded by Bernard Mach in 1998 and is headquartered in Plan-les-Ouates, Switzerland. | Health Services |
| Biopolo Ticino |
- Bolsa de valores
- Insiders
- Luca Bolliger